- Home
- SBFM vs DAKT Comparison
SBFM vs DAKT Comparison
Compare SBFM & DAKT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | SBFM | DAKT |
|---|---|---|
| Founded | 2006 | 1968 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Office Equipment/Supplies/Services |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 7.2M | 872.1M |
| IPO Year | N/A | 1994 |
Fundamental Metrics
Financial Performance| Metric | SBFM | DAKT |
|---|---|---|
| Price | $1.28 | $19.80 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 1 |
| Target Price | $7.00 | ★ $26.00 |
| AVG Volume (30 Days) | 55.7K | ★ 615.4K |
| Earning Date | 11-13-2025 | 12-10-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.15 |
| Revenue | $37,323,742.00 | ★ $770,283,000.00 |
| Revenue This Year | $10.26 | $13.76 |
| Revenue Next Year | $32.63 | $7.35 |
| P/E Ratio | ★ N/A | $135.79 |
| Revenue Growth | ★ 13.24 | N/A |
| 52 Week Low | $1.16 | $10.24 |
| 52 Week High | $3.90 | $24.38 |
Technical Indicators
Market Signals| Indicator | SBFM | DAKT |
|---|---|---|
| Relative Strength Index (RSI) | 35.84 | 58.03 |
| Support Level | $1.16 | $18.16 |
| Resistance Level | $1.40 | $19.08 |
| Average True Range (ATR) | 0.09 | 0.70 |
| MACD | -0.00 | 0.11 |
| Stochastic Oscillator | 34.41 | 66.39 |
Price Performance
Historical ComparisonAbout SBFM Sunshine Biopharma Inc.
Sunshine Biopharma Inc is a pharmaceutical company offering and researching life-saving medicines in a wide variety of therapeutic areas, including oncology and antivirals. Through its subsidiaries, the company has various generic prescription drugs on the market in Canada and is also involved in developing and selling OTC supplements. In addition, the company is conducting a proprietary drug development program, which is comprised of K1.1 mRNA targeted for liver cancer and SBFM-PL4, PLpro protease inhibitor for SARS Coronavirus infections.
About DAKT Daktronics Inc.
Daktronics Inc designs and manufactures electronic scoreboards, programmable display systems, and large-screen video displays for sporting, commercial, and transportation applications. It is engaged in a full range of activities: marketing and sales, engineering and product design and development, manufacturing, technical contracting, professional services, and customer service and support. The company offers a complete line of products, from small scoreboards and electronic displays to large multimillion-dollar video display systems as well as related control, timing, and sound systems. The company has five reportable segments: Commercial, Live Events, High School Park and Recreation, Transportation, and International. The company makes the majority of its revenue from Live events.